Evaluation of ASD Severity in Children Aged 2-6 Years Using the Assessment Treatment Evaluation Checklist

(1) * Neny Triana Mail (Faculty of Medicine, Diponegoro University, Semarang, Indonesia, Indonesia)
(2) Mohammad Sulchan Mail (Nutrition Department, Faculty of Medicine, Diponegoro University, Semarang, Indonesia, Indonesia)
(3) Maria Mexitalia Mail (Pediatric Department, Faculty of Medicine, Diponegoro University, Semarang, Indonesia)
(4) Maria Suryani Mail (Department of Nursing, STIKES Elisabeth Semarang, Indonesia)
*corresponding author


A child can be diagnosed with autism spectrum disorder (ASD) before they are two years old. Children with ASD will show symptoms of social interaction and communication disorders, repetitive behaviours, and an extremely narrow range of activities of interest.  Early ASD treatment will result in significant improvement in ASD symptoms. The assessment treatment evaluation checklist (ATEC) instrument is a commonly used instrument to evaluate the severity of ASD after being given therapy. This study aims to evaluate the severity of ASD in children aged 2-6 years using the ATEC instrument. This study used a cross-sectional design. A total of 66 ASD children aged 2-6 years from the autism clinic selected by simple random sampling were involved in the study. ASD severity was measured with the ATEC instrument by therapists from the autism clinic. Data on respondent characteristics such as gender and age diagnosed with ASD were evaluated. One-way ANOVA test was used in this study. The overall ASD severity at age 2,3,4,5,6 years was 96.45, 99.50, 94.23, 94.83, 100.87 respectively (possible score range is 0-179). There was no difference in the severity of ASD in each age group of children 2-6 years (p=0.878). There is no difference in the severity of ASD in children aged 2-6 years. ASD children need appropriate action to improve the severity of ASD from an early age on an ongoing basis


autism spectrum disorder, children, ATEC, age, severity




Article metrics

10.29099/ijair.v6i1.2.704 Abstract views : 108





D. S. American Psychiatric Association, A. P. Association, and others, Diagnostic and statistical manual of mental disorders: DSM-5, vol. 5. American psychiatric association Washington, DC, 2013.

J. Zeidan et al., “Global prevalence of autism: a systematic review update,” Autism Res., vol. 15, no. 5, pp. 778–790, 2022.

N. Salari et al., “The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis,” Ital. J. Pediatr., vol. 48, no. 1, pp. 1–16, 2022.

S. R. Sharma, X. Gonda, and F. I. Tarazi, “Autism spectrum disorder: classification, diagnosis and therapy,” Pharmacol. Ther., vol. 190, pp. 91–104, 2018.

D. L. Christensen et al., “Prevalence and characteristics of autism spectrum disorder among children aged 4 years—early autism and developmental disabilities monitoring network, seven sites, United States, 2010, 2012, and 2014,” MMWR Surveill. Summ., vol. 68, no. 2, p. 1, 2019.

C. Cheroni, N. Caporale, and G. Testa, “Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology,” Mol. Autism, vol. 11, no. 1, pp. 1–18, 2020.

A. Modabbernia, E. Velthorst, and A. Reichenberg, “Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses,” Mol. Autism, vol. 8, no. 1, pp. 1–16, 2017.

L. A. Sealey et al., “Environmental factors in the development of autism spectrum disorders,” Environ. Int., vol. 88, pp. 288–298, 2016.

A. Chauhan, T. Audhya, and V. Chauhan, “Brain region-specific glutathione redox imbalance in autism,” Neurochem. Res., vol. 37, no. 8, pp. 1681–1689, 2012.

R. Blanc et al., “Early Intervention in Severe Autism: Positive Outcome Using Exchange and Development Therapy,” Front. Pediatr., vol. 9, 2021.

A. P. Kipp et al., “Revised reference values for selenium intake,” J. Trace Elem. Med. Biol., vol. 32, pp. 195–199, 2015.

H. G. Senel, “Parents’ views and experiences about complementary and alternative medicine treatments for their children with autistic spectrum disorder,” J. Autism Dev. Disord., vol. 40, no. 4, pp. 494–503, 2010.

S. Georgiades et al., “Trajectories of symptom severity in children with autism: Variability and turning points through the transition to school,” J. Autism Dev. Disord., vol. 52, no. 1, pp. 392–401, 2022.

S. Mahapatra et al., “Autism Treatment Evaluation Checklist (ATEC) norms: A ‘growth chart’ for ATEC score changes as a function of age,” Children, vol. 5, no. 2, p. 25, 2018.

S. Mahapatra, E. Khokhlovich, S. Martinez, B. Kannel, S. M. Edelson, and A. Vyshedskiy, “Longitudinal epidemiological study of autism subgroups using Autism Treatment Evaluation Checklist (ATEC) score,” J. Autism Dev. Disord., vol. 50, no. 5, pp. 1497–1508, 2020.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


International Journal Of Artificial Intelligence Research

Organized by: Departemen Teknik Informatika STMIK Dharma Wacana
Published by: STMIK Dharma Wacana
Jl. Kenanga No.03 Mulyojati 16C Metro Barat Kota Metro Lampung

Email: jurnal.ijair@gmail.com

View IJAIR Statcounter

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.